| 1 | To approve the consolidated financial statements | For |
| 2 | To approve the parent company's financial statements | For |
| 3 | To approve dividend (1) and dividend reinvestment plan (option for scrip dividend) (2) | Oppose |
| 4 | To approve regulated related-party agreements | Oppose |
| 5 | To approve buy-back of the company shares | For |
| 6 | Re-election of Louis Schweitzer as Director for a period of 3 years | Oppose |
| 7 | Election of Michel Tilmant as Director for a period of 3 years | Oppose |
| 8 | Election of Emiel Van Broekhoven as Director for a period of 3 years | Oppose |
| 9 | Election of Meglena Kuneva as Director for a period of 3 years | For |
| 10 | Election of Jean-Laurent Bonnafé as Director for a period of 3 years | For |
| 11 | Approve director' fees (€975,000) | Oppose |
| 12 | Global authorisation to issue with pre-emptive subscription right shares or other securities giving way to new capital | For |
| 13 | Global allowance to issue capital related securities without pre-emptive right | Oppose |
| 14 | To approve issues of shares or other capital related securities as a payment for any public offer | Oppose |
| 15 | Delegation to issue shares and capital securities as consideration for contributions in kind made to the company | Oppose |
| 16 | To limit capital increases without pre-emption rights | For |
| 17 | To authorise capital increase by transfer of reserves | For |
| 18 | To limit capital increases to € 1,000,000,000 with or without pre-emption rights | For |
| 19 | To approve capital Increase for the employees | Oppose |
| 20 | To approve potential reduction of the company 's capital | For |
| 21 | To approve merger with Fortis Banque involving company's capital increase | For |
| 22 | Modify By-laws about the buy-back of preference shares | For |
| 23 | Delegation of powers for the completion of formalities | For |
